Elanco Animal Health Q3 Adjusted Earnings, Revenue Increase; 2026 Guidance Lifted

06:57 AM EST, 11/06/2026 (MT Newswires) -- Elanco Animal Health (ELAN) reported Q3 adjusted earnings Friday of $0.27 per diluted share, up from $0.19 a year earlier. Analysts polled by FactSet expected $0.20. Revenue for the quarter ended Sept. 30 was $1.27 billion, up from $1.14 billion a year earlier. Analysts expected $1.21 billion. For 2026, the company raised its adjusted EPS guidance to now be between $1.17 and $1.20 from the prior guidance of $1.10 to $1.16. Analysts are expecting $1.13. Revenue for the year is now projected to be between $5.16 billion and $5.18 billion, up from the prior guidance of between $5.09 billion and $5.14 billion. Analysts are looking for $5.14 billion. Shares of the company were up 7% in recent premarket activity. Price: 25.33, Change: +1.65, Percent Change: +6.97